regulatory_compliance

Yale Secures $25M ARIA Grant to Map Developing Brain, Autism Origins

Image
Yale Secures $25M ARIA Grant to Map Developing Brain, Autism Origins

NEW HAVEN, Conn. -- Aug. 31, 2026 -- Yale School of Medicine has secured a nearly $25 million grant from the Aligning Research to Impact Autism (ARIA) initiative to build the first high-resolution map of the developing human brain and pinpoint where autism diverges from typical neural development.

The award, part of ARIA's Human Developmental Neurobiology Research Hub, funds two Yale-led projects within a four-project collaboration that also involves Harvard University. Combined, the initiative targets a gap researchers say has stalled autism drug and diagnostic development for decades: no detailed reference map exists for how the human brain wires itself in the first years of life.

Walnut Coding Ranks No. 44 Globally in TIME's 2026 EdTech List

BEIJING -- Aug. 31, 2026 -- Walnut Coding placed No. 44 among 500 companies in TIME's World's Top EdTech Companies 2026 ranking, the only China-based youth coding education firm to break into the global top 100. The Beijing-founded company ranked sixth among 23 China-based firms on the list, which TIME compiled with market data provider Statista after screening roughly 6,500 education technology companies worldwide.

Financial strength drives 70% of the scoring methodology

Statista weighted revenue, funding and market capitalization at 70% of each company's total score, pulling from public disclosures and company-reported data. The remaining 30% covered industry impact, measured through product reach, alignment with United Nations Sustainable Development Goals, intellectual property holdings and website traffic.

IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

Image
IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

SOUTH SAN FRANCISCO, Calif. -- September 01, 2026 -- IDEAYA Biosciences said its FDA Type C meeting on IDE849, a DLL3-targeting antibody drug conjugate, produced agreement on a Phase 3 registrational trial design for extensive stage small cell lung cancer (ES-SCLC). The Nasdaq-listed company (IDYA) plans to enroll roughly 400 patients who have already received tarlatamab, randomizing them 1:1 between IDE849 monotherapy and an investigator's choice control arm of topotecan and amrubicin. IDEAYA is targeting trial initiation by year-end 2026.

NOP Drill Hole MM26-10 Shows Heavy Metals Well Below Organic Limits

Image
NOP Drill Hole MM26-10 Shows Heavy Metals Well Below Organic Limits

Vancouver, BC -- September 01, 2026 -- Nevada Organic Phosphate Inc. (CSE: NOP, OTCQB: NOPFF) reported that drill hole MM26-10 at its Murdock Mountain project in northeast Nevada returned 10.89% P2O5 over 3.60 metres, with heavy metal contaminant levels far below the thresholds required for organic fertilizer certification. The hole marked a 1.5-kilometre step-out along strike from intercepts the company disclosed Aug. 26, 2026. Nevada Organic Phosphate also disclosed a US$25,000 paid research agreement with Emerging Growth Research LLC to produce an investor report within four to six weeks.

Data Dynamics Debuts Enterprise 2.0.5 at LEAP 2026 for AI Data Governance

Image
Data Dynamics Debuts Enterprise 2.0.5 at LEAP 2026 for AI Data Governance

RIYADH, Saudi Arabia -- August 31, 2026 -- Data Dynamics announced general availability of Enterprise 2.0.5 at LEAP 2026 in Riyadh. The company said 60% of AI projects stall due to data curation and AI-readiness gaps, prompting the release of a platform that enforces governance directly at the data layer. Enterprise 2.0.5 targets models pointed at unmapped data, agents with standing access to content, and compliance teams left proving control after incidents occur. The software is available now across cloud, on-premises, sovereign and air-gapped deployments.

Halfpricesoft Prices ezPaycheck 2026 at $169, Adds Direct IRS E-Filing

Image
Halfpricesoft Prices ezPaycheck 2026 at $169, Adds Direct IRS E-Filing

Redmond, Wash. -- September 01, 2026 -- Halfpricesoft.com priced its updated ezPaycheck 2026 payroll software at $169.00 and added a direct e-file 941 feature that lets employers submit quarterly tax forms straight to the IRS through an authorized electronic system. The Redmond, Washington-based developer made the release available with a 30-day free trial ahead of year-end payroll compliance work for small businesses. The update covers payroll tax tables for all 50 states and Washington, D.C.

ezPaycheck 2026 Routes Form 941 Directly to the IRS

The e-file 941 tool inside ezPaycheck 2026 allows businesses and tax professionals to file federal quarterly tax forms electronically rather than mailing paper submissions. Halfpricesoft.com built the feature into the core application rather than as a separate purchase. The company also sells ezW2, ezACH and integration paths with QuickBooks that connect to the same payroll data set used for the 941 filings.

UTF Pays Entire August Distribution From Capital Gains

SHERIDAN, WYOMING -- August 28, 2026 -- Cohen & Steers Infrastructure Fund, Inc. (NYSE: UTF) will pay shareholders a monthly distribution of $0.1650 per share on August 31, 2026, funded entirely by net realized long-term capital gains, according to a Section 19(a) notice released by Cohen & Steers, Inc. on August 28. The New York-based fund reported zero contribution from net investment income, short-term gains, or return of capital for the August payment. Year-to-date through August 31, the fund has distributed $1.2900 per share, with $0.7259 (56.27%) sourced from long-term capital gains and $0.5641 (43.73%) from net investment income.

Cohen & Steers Fund FOF Pays Aug. Distribution, Zero Return of Capital

SHERIDAN, WYOMING -- August 28, 2026 -- Cohen & Steers Closed-End Opportunity Fund, Inc. (NYSE: FOF) will pay shareholders a monthly distribution of $0.0870 per common share on August 31, 2026, funded entirely by net investment income and realized capital gains, according to a Section 19(a) notice the company issued August 28. None of the payout came from return of capital, the notice showed. The disclosure covers the fund's fiscal year-to-date distributions through August 31, which total $0.6960 per share.

The August payment breaks down as $0.0342 per share, or 39.31%, from net investment income and $0.0528 per share, or 60.69%, from net realized long-term capital gains. No portion came from short-term gains or return of capital. Year-to-date, net investment income accounts for $0.2481 per share (35.65% of total distributions) while long-term gains make up $0.4479 per share (64.35%), with return of capital again at zero.